ASND Ascendis Pharma A/S: Operatsion rentabellik

Ascendis Pharma A/S (ASND) - korporativ logo

Ascendis Pharma A/S (ASND) tibbiyot markazlari bilan hamkorlik orqali o'z kapitalini kengaytirmoqda, bu esa endokrin dori vositalarini bozorga chiqarishni tezlashtirmoqda. Operatsion marja joriy dinamikani aks ettirmoqda va uning qiymati 18.40 darajasida saqlanmoqda. TransCon texnologiyasi kam uchraydigan patologiyalarni davolash uchun sodiq ekotizimni yaratmoqda, Skytrofa ning tijorat muvaffaqiyati esa real moliyaviy oqimni ta'minlab, yangi metabolizm molekulalariga bo'lgan bozor kutuvlarini mustahkamlamoqda.

ASND: Ascendis Pharma Operatsion marja 04.07.2022 - 19.11.2026

Ascendis Pharma A/S kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:ASND, Ascendis Pharma A/S
Ascendis tayyor mahsulotlari

TransCon platformasining shaxsiy terapiya standartlarini joriy etishdagi samaradorligi operatsion foyda marjalarini bevosita belgilaydi va bu umumiy daromad ichidagi operatsion daromad ulushini aks ettiradi. Ushbu ko'rsatkichning tahlili investorlarga Ascendis Pharma A/S (ASND) kompaniyasining texnologik ustunligini qarz xizmatlari va soliq majburiyatlarigacha bo'lgan haqiqiy pul oqimiga aylantirish qobiliyatini baholash imkonini beradi va biznesning bozor qiymati barqarorligini tasdiqlaydi.

Raqobatdosh kompaniyalar

Operatsion rentabellik Madrigal Corp|Corcept Therapeutics Corp (CORT) - Operatsion faoliyat rentabelligi|Operatsion rentabellik rhythmtx.com (RYTM)|Sotuvning operatsion marjasi Akero Therapeutics AKRO|Operatsion rentabellik Metsera, Inc. MTSR|MLTX - Sotuvning operatsion marjasi|CRNX - Operatsion rentabellik|Sotuvning operatsion rentabelligi NewAmsterdam Pharma|Soleno Therapeutics (SLNO) - Operatsion rentabellik|FOLD - Operatsion faoliyat rentabelligi|Operatsion rentabellik 89bio Pharma|Sotuvning operatsion rentabelligi Agios AGIO|Operatsion marja GPCR|MiMedx Group, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Rezolute Bio - Sotuvning operatsion marjasi|lexpharma.com (LXRX) - Sotuvning operatsion rentabelligi|MBX - Operatsion rentabellik|ALT (Altimmune) - Operatsion foyda bo'yicha sotuv rentabelligi|Aardvark Therapeutics Inc. (AARD) - Operatsion rentabellik|Sagimet - Operatsion foyda normasi|BIOA (BioAge Labs, Inc) - Operatsion marja|Operatsion marja biomeafusion.com|Operatsion marja QNCX|GUTS - Sotuvning operatsion rentabelligi|Operatsion marja VTVT (vTv Therapeutics)|ATPC - Sotuvning operatsion marjasi|PLUR - Operatsion rentabellik|Synlogic Inc. (SYBX) - Sotuvning operatsion marjasi|LPCN (Lipocine Inc) - Sotuvning operatsion marjasi|Matinas BioPharma Holdings, Inc. - Operatsion foyda normasi|SPRB (sprucebiosciences.com) - Operatsion marja|Operatsion rentabellik GLTO|Operatsion marja CTCX|Lumos Pharma, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ONVO (organovo.com)|Operatsion foyda bo'yicha marjinallik Radius Health